Literature DB >> 28243864

Hypersomnolence, Hypersomnia, and Mood Disorders.

Lucie Barateau1,2,3, Régis Lopez1,2,3, Jean Arthur Micoulaud Franchi4,5,6, Yves Dauvilliers7,8,9.   

Abstract

Relationships between symptoms of hypersomnolence, psychiatric disorders, and hypersomnia disorders (i.e., narcolepsy and idiopathic hypersomnia) are complex and multidirectional. Hypersomnolence is a common complaint across mood disorders; however, patients suffering from mood disorders and hypersomnolence rarely have objective daytime sleepiness, as assessed by the current gold standard test, the Multiple Sleep Latency Test. An iatrogenic origin of symptoms of hypersomnolence, and sleep apnea syndrome must be considered in a population of psychiatric patients, often overweight and treated with sedative drugs. On the other hand, psychiatric comorbidities, especially depression symptoms, are often reported in patients with hypersomnia disorders, and an endogenous origin cannot be ruled out. A great challenge for sleep specialists and psychiatrists is to differentiate psychiatric hypersomnolence and a central hypersomnia disorder with comorbid psychiatric symptoms. The current diagnostic tools seem to be limited in that condition, and further research in that field is warranted.

Entities:  

Keywords:  Depression; Excessive daytime sleepiness; Hypersomnia; Hypersomnolence; Idiopathic hypersomnia; Mood; Narcolepsy type 1; Narcolepsy type 2; Psychiatric disorders

Mesh:

Year:  2017        PMID: 28243864     DOI: 10.1007/s11920-017-0763-0

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  81 in total

1.  Teen sleep and suicidality: results from the youth risk behavior surveys of 2007 and 2009.

Authors:  Caris T Fitzgerald; Erick Messias; Daniel J Buysse
Journal:  J Clin Sleep Med       Date:  2011-08-15       Impact factor: 4.062

Review 2.  A normative study of the maintenance of wakefulness test (MWT).

Authors:  K Doghramji; M M Mitler; R B Sangal; C Shapiro; S Taylor; J Walsleben; C Belisle; M K Erman; R Hayduk; R Hosn; E B O'Malley; J M Sangal; S L Schutte; J M Youakim
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1997-11

Review 3.  Sleep in patients with remitted bipolar disorders: a meta-analysis of actigraphy studies.

Authors:  P A Geoffroy; J Scott; C Boudebesse; M Lajnef; C Henry; M Leboyer; F Bellivier; B Etain
Journal:  Acta Psychiatr Scand       Date:  2014-11-28       Impact factor: 6.392

4.  Atypical depression: a variant of bipolar II or a bridge between unipolar and bipolar II?

Authors:  Hagop S Akiskal; Franco Benazzi
Journal:  J Affect Disord       Date:  2005-02       Impact factor: 4.839

5.  Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial.

Authors:  Yves Dauvilliers; Claudio Bassetti; Gert Jan Lammers; Isabelle Arnulf; Geert Mayer; Andrea Rodenbeck; Philippe Lehert; Claire-Li Ding; Jeanne-Marie Lecomte; Jean-Charles Schwartz
Journal:  Lancet Neurol       Date:  2013-10-07       Impact factor: 44.182

6.  Prevalence and risk factors of subjective sleepiness in the general adult population.

Authors:  Ståle Pallesen; Inger Hilde Nordhus; Siri Omvik; Børge Sivertsen; Grethe S Tell; Bjørn Bjorvatn
Journal:  Sleep       Date:  2007-05       Impact factor: 5.849

7.  Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007.

Authors:  Timothy Morgenthaler; Cathy Alessi; Leah Friedman; Judith Owens; Vishesh Kapur; Brian Boehlecke; Terry Brown; Andrew Chesson; Jack Coleman; Teofilo Lee-Chiong; Jeffrey Pancer; Todd J Swick
Journal:  Sleep       Date:  2007-04       Impact factor: 5.849

Review 8.  Clinical aspects and pathophysiology of narcolepsy.

Authors:  Yves Dauvilliers; Michel Billiard; Jacques Montplaisir
Journal:  Clin Neurophysiol       Date:  2003-11       Impact factor: 3.708

9.  Risk markers for depression in adolescents: sleep and HPA measures.

Authors:  Uma Rao; Constance L Hammen; Russell E Poland
Journal:  Neuropsychopharmacology       Date:  2009-03-04       Impact factor: 7.853

10.  Absence of NMDA receptor antibodies in the rare association between Type 1 Narcolepsy and Psychosis.

Authors:  Y Dauvilliers; C Gaig; L Barateau; F Graus; A Iranzo; R Lopez; J Santamaria
Journal:  Sci Rep       Date:  2016-05-04       Impact factor: 4.379

View more
  11 in total

1.  Effects of Pharmacotherapy Treatment on Patient-Reported Outcomes in a Narcolepsy and Idiopathic Hypersomnia Cohort.

Authors:  Maeve Pascoe; James Bena; Nancy Foldvary-Schaefer
Journal:  J Clin Sleep Med       Date:  2019-10-30       Impact factor: 4.062

2.  Nocturnal sleep architecture in idiopathic hypersomnia: a systematic review and meta-analysis.

Authors:  David T Plante
Journal:  Sleep Med       Date:  2017-11-02       Impact factor: 3.492

3.  Establishing the objective sleep phenotype in hypersomnolence disorder with and without comorbid major depression.

Authors:  David T Plante; Jesse D Cook; Leonardo S Barbosa; Michael R Goldstein; Michael L Prairie; Richard F Smith; Brady A Riedner
Journal:  Sleep       Date:  2019-06-11       Impact factor: 5.849

4.  Impaired neurobehavioral alertness quantified by the psychomotor vigilance task is associated with depression in the Wisconsin Sleep Cohort study.

Authors:  David T Plante; Erika W Hagen; Laurel A Ravelo; Paul E Peppard
Journal:  Sleep Med       Date:  2019-12-04       Impact factor: 3.492

5.  Determinants of sleepiness in obstructive sleep apnea.

Authors:  Bharati Prasad; Alana D Steffen; Hans P A Van Dongen; Francis M Pack; Inna Strakovsky; Bethany Staley; David F Dinges; Greg Maislin; Allan I Pack; Terri E Weaver
Journal:  Sleep       Date:  2018-02-01       Impact factor: 5.849

6.  The association between traumatic life events and insomnia symptoms among men and women: Results from the Baltimore Epidemiologic Catchment Area follow-up study.

Authors:  Nicole A Short; Anna E Austin; Amy R Wolfson; Darlynn M Rojo-Wissar; Cynthia A Munro; William W Eaton; O Joseph Bienvenu; Adam P Spira
Journal:  Sleep Health       Date:  2022-02-10

7.  Excessive sleepiness and associated symptoms in the U.S. adult population: prevalence, correlates, and comorbidity.

Authors:  Bhanu Prakash Kolla; Jian-Ping He; Meghna P Mansukhani; Mark A Frye; Kathleen Merikangas
Journal:  Sleep Health       Date:  2019-11-02

8.  Escalation of sleep disturbances amid the COVID-19 pandemic: a cross-sectional international study.

Authors:  Uri Mandelkorn; Shir Genzer; Shoham Choshen-Hillel; Joel Reiter; Miguel Meira E Cruz; Hagit Hochner; Leila Kheirandish-Gozal; David Gozal; Alex Gileles-Hillel
Journal:  J Clin Sleep Med       Date:  2021-01-01       Impact factor: 4.062

9.  Self-reported symptoms and objective measures in idiopathic hypersomnia and hypersomnia associated with psychiatric disorders: a prospective cross-sectional study.

Authors:  Jitka Bušková; Tomáš Novák; Eva Miletínová; Radana Králová; Jana Košt Álová; Monika Kliková; Karolina Veldová
Journal:  J Clin Sleep Med       Date:  2022-03-01       Impact factor: 4.062

Review 10.  Preoptic Area Modulation of Arousal in Natural and Drug Induced Unconscious States.

Authors:  Sarah L Reitz; Max B Kelz
Journal:  Front Neurosci       Date:  2021-02-12       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.